Elisabeth E. Fransen van de Putte

2.2k citations

28 papers · 835 indexed · 1 hit paper · h-index 13

Co-authors: Simon Horenblas Richard P. Meijer Bas W.G. van Rhijn Harold A. Harvey Joseph J. Drabick Matthew Kaag Michael Glantz Monika Joshi
Topics: Bladder and Urothelial Cancer Treatments (24 papers)Urinary and Genital Oncology Studies (16 papers)Urological Disorders and Treatments (8 papers)
Cited by: Urology Surgery Oncology
Journals: Journal of Clinical Oncology Hypertension The Journal of Urology
Partner nations: Netherlands Canada United States

In The Last Decade

Elisabeth E. Fransen van de Putte

28 papers receiving 832 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis

2016 314 citations Ming Yin, Monika Joshi et al. The Oncologist profile →

Peers

Countries citing papers authored by Elisabeth E. Fransen van de Putte

Since Specialization

Citations

This map shows the geographic impact of Elisabeth E. Fransen van de Putte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth E. Fransen van de Putte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth E. Fransen van de Putte more than expected).

Fields of papers citing papers by Elisabeth E. Fransen van de Putte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth E. Fransen van de Putte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth E. Fransen van de Putte. The network helps show where Elisabeth E. Fransen van de Putte may publish in the future.

Co-authorship network of co-authors of Elisabeth E. Fransen van de Putte

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth E. Fransen van de Putte. A scholar is included among the top collaborators of Elisabeth E. Fransen van de Putte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth E. Fransen van de Putte. Elisabeth E. Fransen van de Putte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease? 2023 ·European Urology Open Science ·Elisabeth E. Fransen van de Putte,(unknown),M. A. Mansour,Johannes C. van der Mijn,Sofie Wilgenhof,Johannes V. van Thienen,John B.A.G. Haanen,Ekaterini Boleti,Thomas Powles,Patricia Zondervan,Niels M. Graafland,Axel Bex	8
2	Results of the York Mason Procedure with and without Concomitant Graciloplasty to Treat Iatrogenic Rectourethral Fistulas 2019 ·European Urology Focus ·Maarten J. van der Doelen,Elisabeth E. Fransen van de Putte,Simon Horenblas,John Heesakkers	2
3	Prostate sparing cystectomy for bladder cancer: A two-center study 2018 ·European Journal of Surgical Oncology ·Charlotte S. Voskuilen,Elisabeth E. Fransen van de Putte,(unknown),Erik van Werkhoven,Laura S. Mertens,Bas W.G. van Rhijn,Mohamed Saad,Axel Bex,Xavier Cathelineau,Henk G. van der Poel,Simon Horenblas,Rafael Sanchez‐Salas,Richard P. Meijer	9
4	The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer 2018 ·British Journal of Urology ·Elisabeth E. Fransen van de Putte,Judith Bosschieter,Theodorus van der Kwast,Simone Bertz,Stefan Denzinger,(unknown),Éva Compérat,Joost L. Boormans,Michael A.S. Jewett,Robert Stoehr,Geert J.L.H. van Leenders,Jakko A. Nieuwenhuijzen,Alexandre R. Zlotta,Kees Hendricksen,Morgan Rouprêt,Wolfgang Otto,Maximilian Burger,Arndt Hartmann,Bas W.G. van Rhijn	23
5	Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non–muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors 2018 ·Clinical Genitourinary Cancer ·Judith Bosschieter,Anouk E. Hentschel,C. Dilara Savci‐Heijink,J. Patrick van der Voorn,Lawrence Rozendaal,André N. Vis,Bas W.G. van Rhijn,Birgit I. Lissenberg‐Witte,Elisabeth E. Fransen van de Putte,R. Jeroen A. van Moorselaar,Jakko A. Nieuwenhuijzen	14
6	Dose dense MVAC prior to radical cystectomy: a real-world experience 2017 ·World Journal of Urology ·Homayoun Zargar,Jay B. Shah,Elisabeth E. Fransen van de Putte,Kylea Potvin,Kamran Zargar‐Shoshtari,Bas W. van Rhijn,Siamak Daneshmand,Jeff M. Holzbeierlein,Philippe E. Spiess,Eric Winquist,Simon Horenblas,Colin P. Dinney,Peter C. Black,Wassim Kassouf	9
7	Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function 2017 ·Urologia Internationalis ·Elisabeth E. Fransen van de Putte,Liesbeth L. de Wall,Erik van Werkhoven,(unknown),Axel Bex,Henk G. van der Poel,Bas W.G. van Rhijn,Simon Horenblas,Kees Hendricksen	8
8	FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy 2017 ·International Urology and Nephrology ·Elisabeth E. Fransen van de Putte,Erik Vegt,Laura S. Mertens,Annemarie Bruining,Kees Hendricksen,Michiel S. van der Heijden,Simon Horenblas,Bas W.G. van Rhijn	22
9	Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube 2017 ·World Journal of Urology ·Charlotte S. Voskuilen,Elisabeth E. Fransen van de Putte,(unknown),Erik van Werkhoven,(unknown),Bas W.G. van Rhijn,Simon Horenblas,Richard P. Meijer	9
10	Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysisbreakdown → 2016 ·The Oncologist ·Ming Yin,Monika Joshi,Richard P. Meijer,Michael Glantz,Sheldon L. Holder,Harold A. Harvey,Matthew Kaag,Elisabeth E. Fransen van de Putte,Simon Horenblas,Joseph J. Drabick	314
11	Variations in pelvic lymph node dissection in invasive bladder cancer: A Dutch nationwide population-based study during centralization of care 2016 ·Urologic Oncology Seminars and Original Investigations ·(unknown),Elisabeth E. Fransen van de Putte,L. Fossion,Erik van Werkhoven,Rob H.A. Verhoeven,(unknown),Simon Horenblas	16
12	Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling 2016 ·Hypertension ·(unknown),Alicja Czopek,(unknown),Nicholas S. Kirkby,Elisabeth E. Fransen van de Putte,(unknown),(unknown),(unknown),(unknown),Yuri Kotelevtsev,Rhoda E. Kuc,Anthony P. Davenport,Neeraj Dhaun,David J. Webb,Patrick W. F. Hadoke	12
13	Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer—Results of a nationwide population-based study 2016 ·European Journal of Cancer ·(unknown),Elisabeth E. Fransen van de Putte,Simon Horenblas,Richard P. Meijer,Joost L. Boormans,Katja K.H. Aben,Michiel S. van der Heijden,Ronald de Wit,Laurens V. Beerepoot,Rob H.A. Verhoeven,Bas W.G. van Rhijn	33
14	Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy 2016 ·The Journal of Urology ·Wilhelmina Duivenvoorden,Siamak Daneshmand,Daniel Canter,Yair Lotan,Peter C. Black,Hamidreza Abdi,Bas W.G. van Rhijn,Elisabeth E. Fransen van de Putte,Piotr Zareba,(unknown),Wassim Kassouf,(unknown),Janet Baack Kukreja,Peter J. Boström,Bobby Shayegan,Jehonathan H. Pinthus	27
15	Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder 2015 ·Current Opinion in Urology ·Elisabeth E. Fransen van de Putte,(unknown),Garry L.S. Pigot,Theodorus van der Kwast,Bas W.G. van Rhijn	22
16	ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy 2015 ·European Urology ·Floris H. Groenendijk,Jeroen de Jong,Elisabeth E. Fransen van de Putte,Magali Michaut,Andreas Schlicker,Dennis Peters,Arno Velds,Marja Nieuwland,Michel M. van den Heuvel,Ron Kerkhoven,Lodewijk F.A. Wessels,Annegien Broeks,Bas W.G. van Rhijn,René Bernards,Michiel S. van der Heijden	168
17	Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template 2015 ·Urologic Oncology Seminars and Original Investigations ·Elisabeth E. Fransen van de Putte,(unknown),Erik van Werkhoven,Laura S. Mertens,Richard P. Meijer,Axel Bex,(unknown),Henk G. van der Poel,Bas W.G. van Rhijn,Simon Horenblas	11
18	Perioperative treatment and radical cystectomy for bladder cancer – a population based trend analysis of 10,338 patients in the Netherlands 2015 ·European Journal of Cancer ·(unknown),Elisabeth E. Fransen van de Putte,Simon Horenblas,V.E.P.P. Lemmens,Katja K.H. Aben,Michiel S. van der Heijden,Laurens V. Beerepoot,Rob H.A. Verhoeven,Bas W.G. van Rhijn	34
19	Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin 2015 ·World Journal of Urology ·Elisabeth E. Fransen van de Putte,Laura S. Mertens,Richard P. Meijer,Michiel S. van der Heijden,Axel Bex,Henk G. van der Poel,J. Martijn Kerst,Andries M. Bergman,Simon Horenblas,Bas W.G. van Rhijn	42
20	Priapism following continuous thoracic epidural anaesthesia: emergency or a benign condition? 2014 ·Acta Anaesthesiologica Scandinavica ·Elisabeth E. Fransen van de Putte,Hildo J.K. Ananias,(unknown),Hans D. de Boer	4

About Elisabeth E. Fransen van de Putte

Elisabeth E. Fransen van de Putte is a scholar working on Urology, Surgery and Internal Medicine, having authored 28 papers that have together received 835 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (24 papers), Urinary and Genital Oncology Studies (16 papers) and Urological Disorders and Treatments (8 papers). The work is most often cited by research in Urology (234 citations), Surgery (733 citations) and Oncology (211 citations). Elisabeth E. Fransen van de Putte has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Simon Horenblas, Richard P. Meijer, Bas W.G. van Rhijn, Harold A. Harvey, Joseph J. Drabick, Matthew Kaag, Michael Glantz, Monika Joshi, Ming Yin and Sheldon L. Holder. Their work appears in journals such as Journal of Clinical Oncology, Hypertension and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact